subset of 19 women in a previous study in each of whom sufficient serum was available to carry out the assays described below.
The amino acid sequence of C. trachomatis hsp6O as deduced from the DNA sequence by Cerrone et al. (4) was used to direct the synthesis of 533 overlapping 12-mer peptides covering the entire sequence and overlapping by all but a single residue with a commercially available kit (Cambridge Research Biochemicals, Cambridge, U.K.) (5) . Antibodies in sera from immunized rabbits and those in sera from infected women were assayed for binding to peptides by peptide-enzyme-linked immunosorbent assay (ELISA) as described previously (12, 13, 15) . The eight human serum samples were also titrated for antibody to chlamydial recombinant hsp60 by an ELISA. Figure 1 shows the peptide epitope patterns in hsp60 recognized by the 13 rabbits immunized with viable serovar B, C, and L2 EBs, respectively. A pattern of common epitopes among all rabbits was consistently observed, although individual heterogeneity was also apparent. No marked difference in epitope patterns was apparent among the three different serovars for rabbits immunized with EBs, consistent with the known conservation of hsp6O among all members of the genus Chlamydia (9) . Although epitopes are distributed throughout the entire sequence, the region from amino acid (aa) 283 (Fig. 3) . The data show that six epitopes (E1, E2, E5, H3, E8, and E9) are relatively specific to the chlamydial sequence, with the human antisera binding to the chlamydial peptide sequence at a significantly (P < 0.05) higher OD than it does to the human peptide sequence. In particular, epitope E8 is absolutely specific to the chlamydial sequence. The remaining seven epitopes (H1, E3, H2, E4, E6, E7, and Elo) were cross-reactive between the chlamydial and human hsp60 sequences.
These results expand on those previously reported by Cerrone et al. (4) . These researchers used deletion fragments of the glutathione S-transferase hsp6O fusion protein and found that the B-cell epitopes as recognized by antisera from five women with C. trachomatis-associated pelvic inflammatory disease or ectopic pregnancies were restricted to fragments at the carboxy terminus between aa 274 to 402 or aa 405 to 544. Using the pepscan assay, we found that antigenic sites are distributed throughout the entire sequence, although the COOH half of the protein expresses predominantly chlamydia-specific epitopes.
The goal of this study was to determine whether the antibodies that are induced to chlamydial hsp6O are crossreactive between human and chlamydial hsp60. Direct sequence comparison of epitopes from chlamydial hsp60 with homologous regions in human mitochondrial hsp60 shows that antibodies to the major epitopes are directed to regions that vary in sequence. However, when peptides homologous to the human sequence are used in the pepscan assay, antibodies that bind to the human sequence are found in sera from women with C. trachomatis-associated fallopian tube 4 - 3 . Thirteen major peptide epitopes from chlamydial hsp60 were used to detect homologous sequences in human mitochondrial hsp60 (6) . 12-mer peptides were synthesized in the pepscan format and tested with the eight serum samples from women with C. trachomatisassociated ectopic pregnancies (each sample was tested at a dilution of 1:200 damage. Differences between chlamydial and human hsp60 in their amino acid sequences did not accurately predict which epitopes were specific or cross-reactive. Antigenic cross-reactivity may depend on specificity or epitopeparatope immunochemistry, as has been seen previously in studies of the antigenic structure of the chlamydial major outer membrane protein (13) .
We hypothesize that cross-reactive antibodies are induced by chlamydial hsp60 during infection. The role played by such antibodies in disease pathogenesis remains to be clarified. The present observations are consistent with the notion that autoimmune responses to human hsp60 as mediated by serum antibodies or by T cells may contribute to chlamydial disease pathology. Further elucidation of T-cell epitopes, major histocompatibility complex-binding peptides, and peptide-specific cytokine secretion by T-cell subsets is needed in order to fully evaluate the immunologic properties of chlamydial hsp6O and its relationship to disease pathogeneSiS.
